阿迪普辛在心血管疾病的发病过程中的作用
1Department of Surgery, University of Missouri School of Medicine, Columbia, MO, USA.
Vascular pharmacology
|December 19, 2023
概括
素,也称为补充因子-D (CFD),与心血管疾病 (CVD) 风险有关. 素水平升高可能会促进血管问题,并作为心血管疾病的预后标志物.
科学领域:
- 生物化学 生物化学
- 免疫学 免疫学 免疫学
- 心血管科学 心血管科学
背景情况:
- 素 (补充因子-D,CFD) 是一种对补充系统至关重要的素.
- 补充剂过度激活与心血管疾病 (CVD) 病原发生有关.
- 阿迪普辛在心血管疾病病因学中的作用正在调查中,尽管它具有预后意义.
研究的目的:
- 审查阿迪普辛对心血管疾病发病的贡献.
- 为了突出阿迪普辛在心血管细胞功能中的作用.
主要方法:
- 对素和心血管疾病现有研究的文献综述.
- 分析素对内皮细胞,光滑肌肉和免疫细胞的影响.
主要成果:
- 增加的素水平与血管功能障碍,炎症和内皮损伤相关.
- 阿迪普辛与冠状动脉疾病患者的不良结果有关.
- 阿迪普辛与诸如肺动脉高血压,大动脉动脉瘤,子前期和2型糖尿病等疾病有关.
结论:
- 血清脂肪素是心血管疾病的潜在预后标志物.
- 阿迪普辛通过其对关键细胞类型的影响影响心血管功能.
- 需要进一步的实验研究来阐明素在心血管疾病发展中的确切作用.
更多相关视频
06:35Author Spotlight: Insights into Cardiometabolic Diseases with Subcutaneous Adipose Tissue Microvasculature Studies
Published on: April 5, 2024
1.0K
08:41Assessment of Vascular Tone Responsiveness using Isolated Mesenteric Arteries with a Focus on Modulation by Perivascular Adipose Tissues
Published on: June 3, 2019
9.9K
相关概念视频
Phosphoinositides and PIPs
8.5K
Phosphoinositides are a group of phospholipids containing a glycerol backbone with two fatty acid chains and a phosphate attached to a myoinositol sugar ring. The inositol head group extends into the cytoplasm, where it is modified by adding phosphate groups to form phosphatidylinositol phosphates or PIPs.
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
8.5K
IP3/DAG Signaling Pathway
12.1K
Membrane lipids such as phosphatidylinositol (PI) are precursors for several membrane-bound and soluble second messengers. Specific kinases phosphorylate PI and produce phosphorylated inositol phospholipids. One such inositol phospholipids are the phosphatidylinositol-4,5 bisphosphate [PI(4,5)P2], present in the inner half of the lipid bilayer. Upon ligand binding, GPCR stimulates Gq proteins to turn on phospholipase Cꞵ. Activated phospholipase Cꞵ cleaves PI(4,5)P2 and...
12.1K
cAMP-dependent Protein Kinase Pathways
6.4K
Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
6.4K
Adrenergic Receptors: ɑ Subtype
1.5K
Adrenoceptors are classified into α and ꞵ classes based on their potencies to catecholamine agonists. α-adrenoceptors show the following order of catecholamine potency:
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
1.5K
Adherens Junctions
4.8K
Strong contact points between adjacent cells anchor them to each other, forming tissues. Such anchoring junctions are of two types – adherens junctions and desmosomes. Adherens junctions are abundant in tissues such as epithelium and endothelium, forming a continuous zone of adhesion called the adhesion belt. In other tissues, such as heart muscle, they appear as clusters, linking the cells to produce coordinated heart muscle contraction.
Adherens Junctions are Dynamic
Adherens Junctions are Dynamic
4.8K
Transducer Mechanism: Enzyme-Linked Receptors
2.5K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.5K
